Programa TELEO
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Programa TELEO
Jun 24, 2024, 14:24 |
Blog
Guillermo Chantada: Great work by Claudia Sampor with the TELEO Program and retinoblastoma
Guillermo Chantada recently shared on X: “Great work by Claudia Sampor with the TELEO Program and…
Jun 11, 2024, 02:49 |
Blog
Join us if you are interested in pediatric oncology research - Programa TELEO
Programa TELEO shared a post on LinkedIn: “NEXT THURSDAY JUNE 13TH! If you are interested in…
Apr 8, 2024, 14:44 |
Blog
Maite Gorostegui: Programa TELEO gives us a unique space to share knowledge and experience
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post by Ana Carolina…
Mar 12, 2024, 15:34 |
Blog
Ruzanna Papyan: March 14 - let’s join for a deep dive into Caitlyn Duffy's excellent paper on pediatric acute lymphoblastic leukemia outcomes in South American centers
Ruzanna Papyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Mar 7, 2024, 16:48 |
Blog
Maite Gorostegui: Thank you Foundation S. Programa TELEO is certainly doing a huge impact in Latin America, and beyond...
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post by Foundation S…
Oct 27, 2023, 13:29 |
Blog
Guillermo Chantada: How did researchers survive the Valley of Death of publications?
Guillermo Chantada, President of the International Society of Paediatric Oncology (SIOP), shared a post by…
Oct 22, 2023, 18:13 |
Blog
Save the date for "Deconstructing papers" webinar hosted by Guillermo Chantada - Programa TELEO
Programa TELEO shared on their LinkedIn page: ''If you are interested in research and want…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube